Peering at the article on the computer screen I felt a familiar rush of tears. As a health visitor, I knew it was a priority to remain on top of medical research but this latest news about drug treatments for cystic fibrosis (CF) sufferers hit a nerve.
It was June 2023 and I had just finished reading a feature about how a leading combination drug was now helping ease lung damage for those living with advanced CF. Average life expectancy for people with CF used to be around 30 to 40 years, but with new drug breakthroughs like this, it may have improved to 70.
It was, of course, wonderful news and would change the life of
